NEW YORK, May 4, 2015 – Gillian Small, CUNY Vice Chancellor for Research and Executive Director of the CUNY Advanced Science Research Center, participated in a symposium on New York Regenerative Medicine on Monday, May 4 at the Time Warner Center.
The symposium, which focused on the potential for personalized medical care in the wake of research breakthroughs in stem cell biology and other fields, also featured Susan Solomon (President and CEO, New York Stem Cell Foundation), Eric Schadt (Director of the Icahn Institute for Genomics and Multiscale Biology), Sandra Engle (Senior Principal Scientist, Pfizer) and Marc Tessier-Lavigne (President, Rockefeller University).
The subject is increasingly relevant, especially given the recent announcement of the Precision Medicine Initiative by President Obama. The initiative is aimed to accelerate the realization of disease treatment and prevention that accounts for the individual. Precision medical practices are currently used for the treatment of some cancers, but researchers hope to make them the norm for most diseases
Dr. Small is a widely published cell biologist, with a concentration in molecular, cellular and developmental biology. She is the chief architect of CUNY’s explosive growth in science research bringing vision and talent to the ASRC, CUNY and New York. This, along with her work at CUNY in developing partnerships and collaborations with other prestigious institutions with a goal of developing practical outcomes for research, makes her a much sought after speaker.
About the NewYorkBIO Conference: The NewYorkBIO Conference, celebrating its 25th anniversary, has served as a voice for the New York life science community, seeking to help define the industry, protect its interests and grow its opportunities. This year’s conference featured two days of programming, with more than 24 informative panels, a “Pitch & Partner” forum with 30 emerging companies and keynote speeches from Robert Urban (Head of Johnson & Johnson Innovation) and Siddhartha Mukherjee (Assistant Professor of Medicine at Columbia University and author of The Emperor of All Maladies).
About the ASRC: The new CUNY Advanced Science Research Center (ASRC) is a University-wide venture that elevates CUNY’s legacy of scientific research and education through initiatives in five distinctive, but increasingly interconnected disciplines: Nanoscience, Photonics, Structural Biology, Neuroscience and Environmental Science. Led by Dr. Gillian Small, Vice Chancellor for Research and the ASRC’s Executive Director, the center is designed to promote a unique, interdisciplinary research culture. Researchers from each of the initiatives work side by side in the ASRC’s core facilities, sharing equipment that is among the most advanced available.